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Abstract
Background: Influenza A virus is a zoonotic pathogen that poses a major threat to human and animal health. The
severe course of influenza infection is not only influenced by viral virulence factors but also by individual
differences in the host response. To determine the extent to which the genetic background can modulate severity
of an infection, we studied the host responses to influenza infections in the eight genetically highly diverse
Collaborative Cross (CC) founder mouse strains.
Results: We observed highly divergent host responses between the CC founder strains with respect to survival,
body weight loss, hematological parameters in the blood, relative lung weight and viral load. Mouse strain was the
main factor with highest effect size on body weight loss after infection, demonstrating that this phenotype was
highly heritable. Sex represented another significant main effect, although it was less strong. Analysis of survival
rates and mean time to death suggested three groups of susceptibility phenotypes: highly susceptible (A/J, CAST/
EiJ, WSB/EiJ), intermediate susceptible (C57BL/6J, 129S1/SvImJ, NOD/ShiLtJ) and highly resistant strains (NZO/HlLtJ,
PWK/PhJ). These three susceptibility groups were significantly different with respect to death/survival counts. Viral
load was significantly different between susceptible and resistant strains but not between intermediate and highly
susceptible strains. CAST/EiJ mice showed a unique phenotype. Despite high viral loads in their lungs, CAST/EiJ
mice exhibited low counts of infiltrating granulocytes and showed increased numbers of macrophages in the lung.
Histological studies of infected lungs and transcriptome analyses of peripheral blood cells and lungs confirmed an
abnormal response in the leukocyte recruitment in CAST/EiJ mice.
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Conclusions: The eight CC founder strains exhibited a large diversity in their response to influenza infections. Therefore,
the CC will represent an ideal mouse genetic reference population to study the influence of genetic variation on the
susceptibility and resistance to influenza infections which will be important to understand individual variations of disease
severity in humans. The unique phenotype combination in the CAST/EiJ strain resembles human leukocyte adhesion
deficiency and may thus represent a new mouse model to understand this and related abnormal immune responses to
infections in humans.
Keywords: Influenza susceptibility, Collaborative cross, Phenotyping, Mouse model, Immune response
Background
Every year, about 500,000 people die world-wide from
influenza virus infections [1]. In recent history, the
emergence of new influenza subtypes has caused several
pandemics [2–4]. The most severe pandemic in 1918
resulted in about 30–50 million deaths worldwide [5]
and a new variant of a seasonal H1N1 virus, pH1N1,
caused a world-wide pandemic in 2009 [6, 7]. The
course and outcome of an infection is determined by
pathogen virulence, environmental and host factors.
Genetic diversity of the host has been found as an im-
portant factor that strongly influences the host response
and severity to influenza infections in humans [8–12].
Environmental and genetic factors can be well controlled
in experimental animal models. It has been shown in
mouse models that the genetic make-up of the host
strongly influences the disease outcome after influenza
infections (reviewed in [11, 13]). Subsequently, several
genes have been described also in humans that contrib-
ute to disease severity [14].
Mouse genetic reference populations (GRPs) have be-
come an important experimental system that allows inves-
tigating the influence of genetic variation on human
diseases (reviewed in [15–21]. In addition, GRPs have
been used to study the influence of genetic variation on
the host response to infectious pathogens (reviewed in
[13, 22–24]. The Collaborative Cross (CC) is a recently
created population that has been generated from eight
inbred mouse strains, referred to as founder [25]. The
addition of three wild-derived strains (CAST/EiJ, PWK/
PhJ and WSB/EiJ) strongly enhanced the genetic diversity
of the CC [26]. Several studies in not fully inbred CC
strains (pre-CC strains) and CC strains themselves led to
the identification of quantitative trait loci (QTLs) influen-
cing human diseases [27–31]. More recently, CC F1
hybrids have been identified that exhibited severe
hemorrhagic fever, similar to humans, after infection with
Ebola virus [32]. Another CC strain has been shown to
represent a new model for spontaneous colitis [33].
Here, we investigated the pathology, disease severity
and the host response in the eight CC founder strains to
H3N2 influenza A virus infections. We observed a broad
range of phenotypic outcomes for many pathological
and molecular parameters. Also, we found a specific de-
fect in highly susceptible CAST/EiJ mice that resembled
leukocyte recruitment deficiency in humans.
Results
Three different groups of susceptibility phenotypes are
observed after infection of CC founder strains with H3N2
virus
Eight to twelve weeks old female and male mice of the
eight founder strains were infected intra-nasally with a
dose of 1 × 101 FFU of the mouse-adapted influenza
virus subtype H3N2 (A/HK/01/68). Survival rates of in-
fected mice were monitored for a period of 14 days
(Fig. 1). Our results suggest three different susceptibility
groups based on survival rates and mean time to death:
Highly susceptible, intermediate susceptible and highly
resistant strains. Pair-wise chi-square tests between the
three groups revealed significant differences for the
death/survival counts (Additional file 1: Table S1). The
strains A/J, CAST/EiJ and WSB/EiJ belonged to the
highly susceptible group in which all infected mice died.
NZO/HlLtJ and PWK/PhJ were found to be highly re-
sistant; all infected mice survived the infection. Three
strains, C57BL/6J, 129S1/SvImJ and NOD/ShiLtJ,
showed intermediate susceptibility with survival rates
ranging from 10 % to 90 %. No significant differences
were observed in the survival curves of male and female
mice for all strains except for NOD/ShiLtJ, whereby fe-
males were more susceptible than males. At an increased
infection dose of 2 × 103 FFU all mice from highly and
intermediate susceptible strains (A/J, C57BL/6J, 129S1/
SvImJ, NOD/ShiLtJ, CAST/EiJ and WSB/EiJ) succumbed
to the infection (Fig. 1). In contrast, the two highly
resistant strains (NZO/HlLtJ and PWK/PhJ) were also
resistant to infections with higher infection doses of 2 ×
103 FFU and 2 × 105 FFU (Fig. 1). For all strains, except
the highly resistant ones, survival rates in females and
males at the lower dose were significantly higher than
survival rates at higher doses (Fig. 1).
Next, we analyzed mean time to death (MTTD) to
investigate how rapidly susceptible mice succumbed to
infection. At an infection dose of 1 × 101 FFU, the highly
susceptible strains exhibited the lowest MTTD. The
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Fig. 1 Survival rates of the eight CC founder strains after infection with different doses of influenza A H3N2 virus infection. Eight to twelve weeks
old female and male mice of the CC founder strains were infected intra-nasally with 1 × 101 (red and blue), 2 × 103 (orange and green) and 2 ×
105 FFU (magenta and black) of the mouse-adapted influenza H3N2 virus (A/HK/01/68). Survival rates were monitored for 14 days p.i.. Mice that exhibited a
weight loss of more than 30 % relative to their starting weight were euthanized and scored as dead. Significant sex-specific differences in survival curves
were observed exclusively in NOD/ShiLtJ mice after infection with 1 × 101 FFU (**: p-value < 0.01, using log rank test). Colors for the CC founder strains
have been chosen according to the CC strain RGB color code displayed at http://csbio.unc.edu/CCstatus/index.py.
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MTTD was 7 and 9 days p.i. whereas the intermediate
susceptible strains died at day 11 to 14 p.i. (Fig. 2a). At
higher infection dose (2 × 103 FFU) the highly suscep-
tible (day 5 to 6) and the intermediate susceptible group
(day 7 to 8) had a lower MTTD (Fig. 2b). When compar-
ing male and female mice, a significant difference of
MTTD was found for NOD/ShiLtJ and WSB/EiJ mice at
the low virus dose whereas at the high infection dose,
only C57BL/6J mice exhibited a sex-dependent differ-
ence in MTTD (Fig. 2).
Infection of CC founder strains leads to highly variable
body weight changes
In a previous study [34], body weight changes in CC
mice were recorded daily until day 4 after infection with
H1N1 (A/PR/8/34 (PR8)) virus. In our studies, we aimed
Fig. 2 Sex-specific differences in mean time to death at different doses of influenza A H3N2 virus infection in C57BL/6J, NOD/ShiLtJ and WSB/EiJ.
The same data set and color code as in Fig. 1 was used to analyze mean time to death (MTTD) of the strains (clear bars: female; dashed bars:
male mice). Changes in MTTD were calculated for 14 days p.i., survival was scored as an MTTD value of 15. Significant sex-specific differences were
calculated for infection with 1 × 101 FFU (a) and 2x103 FFU (b). NOD/ShiLtJ and WSB/EiJ exhibited significant sex-specific differences in infections
with 1 × 101 FFU and C57BL/6J in infections with 2 × 103 FFU. The dashed line marks the end of experiment. Significances were calculated using
Mann Whitney U test and are marked by stars (*: p < 0.1; **: p < 0.01)
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to provide a more complete phenotype description after
H3N2 infection that covers all phases of the host re-
sponse (innate, adaptive and recovery). Therefore, we
measured body weight changes at each day after infec-
tion until recovery of body weight after 14 days p.i.. We
also included both sexes in our study. The analysis of
body weight changes over 14 days confirmed a large
phenotypic diversity between susceptible and resistant
strains and also within susceptible and resistant groups
(Fig. 3). In addition, the resistant strains were infected
with a dose of 2 × 105 FFU. In this case, NZO/HlLtJ
mice showed a drop in body weight (10 %) at day 2
which stayed low until day 14 after infection whereas
PWK/PhJ showed higher body weight loss (10-20 %) at
early days after infection and rapidly regained weight
from day 4 on (Fig. 3).
A multi-factorial analysis of variance (ANOVA) was
performed to investigate variation of body weight change
as response to infection for the factors strains, sex and
days. The analysis was limited to days 1 to 7 p.i. because
for some strains (A/J, CAST/EiJ, and WSB/EiJ), more
than 60 % of infected mice died by day 8. Thus, the sur-
viving mice were not any more representative for the
group. ANOVA (model: body weight loss ~ strain * sex *
day and deleting the non-significant interaction strain:-
day:sex) revealed that all main effects (strain, sex and
day) and all pair-wise interactions were significant (Add-
itional file 2: Table S2). Subsequent Tukey-HSD post-
hoc test was used to determine significance of pairs
(strain by day p.i.; Additional file 3: Table S3). The
changes in body weight were most pronounced on day 7
p.i.. Strains A/J, CAST/EiJ, and WSB/EiJ exhibited the
highest loss of body weight whereas NZO/HlLtJ was
least affected. The broad-sense heritability was deter-
mined for each day separately and ranged from 0.28 to
0.65 (Table 1) indicating high heritability of this trait.
The sex-effect (using the optimized AVOVA model) was
significant from days 3 to 7 p.i. but with a lower effect
size (maximum of 8 %, Table 1).
Comparisons for all strains over 14 days p.i. (Fig. 3) con-
firmed that female mice from the highly and intermediate
susceptible group exhibited a higher weight loss than male
mice at the lower infection dose of 1 × 101 FFU (Fig. 3).
For the resistant strains NZO/HlLtJ and PWK/PhJ no dif-
ferences between sexes were observed (Fig. 3). In contrast,
at the higher infection dose (2 × 103 FFU) no significant
differences were observed between males and females ex-
cept for some single days for C57BL/6J on day 3 and 4,
PWK/PhJ on days 2, 11, 12 and 14 and WSB/EiJ on day 2
(Fig. 3). Male mice generally showed less severe changes
in body weight than females. Only for the PWK/PhJ strain
female mice exhibited significantly less body weight loss
than male mice. However, this was only observed late after
infection for days 11, 12 and 14.
Selection of infection dose and gender for further
experiments
For all following studies, we decided to perform infections
with a dose of 1 × 101 FFU because at this dose, variation
between the founder strains was highest for survival,
MTTD and body weight changes. Also, we limited the fol-
lowing analyses to female mice. Females were used exten-
sively in our and other laboratories studies thus allowing
better comparability to existing data than males. In
addition, the sex effect was relatively small (ANOVA)
compared to the strain effect. Also, in this study, we
mainly focused on effects caused by genetic variation
which is represented by the strain effect (heritability).
Therefore, the additional information gained by including
males would have been rather limited in our studies and,
with respect to the 3R principle, was omitted.
Increase in relative lung weight differs among CC founder
strains
The relative lung weight (wet lung weight relative to
body weight on day of preparation) was investigated at
different days after infection as measurement for the de-
gree of immune cell infiltration and fluid influx into the
lung (Fig. 4). For highly susceptible strains the relative
lung weight increased significantly on day 5 p.i.. Lung
weight increased for intermediate susceptible strains and
reached a peak at day 8 p.i.. Resistant strains showed
only a slight increase in relative lung weight on day 5 p.i.
and 8 p.i.. To confirm that the increase in relative lung
weight was not simply due to the loss in body weight at
the respective days p.i., we also calculated relative lung
weight for the different days p.i. with reference to the
starting body weight. Also in this case, we still observed
a significant increase in relative lung weight in suscep-
tible strains and no significant increase in the two resist-
ant strains (data not shown).
Kinetics of viral load in lungs revealed large differences
between resistant and susceptible CC founder strains
To investigate if the severity of infection was related to
viral replication in the lungs of mice, we determined
viral load at different time points (day 3, 5 and 8) post
infection. All highly and intermediate susceptible strains
(A/J, CAST/EiJ, WSB/EiJ, C57BL/6J, 129S1/SvlmJ,
NOD/ShiLtJ) showed similar high viral loads of about
105 FFU at all time points analyzed (Fig. 5). In contrast,
the highly resistant strains NZO/HlLtJ and PWK/PhJ
had much lower viral titers in the lung (Fig. 5). PWK/
PhJ exhibited lowest viral loads of all strains (103 FFU/
lung) and no increase between day 3 and 5 whereas
NZO/HlLtJ mice showed an increase in viral load from
day 3 to day 5 p.i. (Fig. 5). Both strains had cleared the
virus from their lungs by day 8 p.i.. Viral load was sig-
nificantly different on day 3 and day 5 p.i. between
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Fig. 3 Dose-dependent differences in body weight changes after influenza A H3N2 virus infection. The same data set and color code as in Fig. 1 was
used. Changes in body weight were monitored for 14 days p.i.. Significant sex-specific differences were observed in all CC founder strains and were
calculated by Mann Whitney U test (*: p< 0.1; **: p< 0.01; ***: p< 0.001; black asterisk: 1 × 101 FFU; grey asterisk: 2 × 103 FFU; blue asterisk: 2 × 105 FFU)
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susceptible and resistant mice but not different between
highly and intermediate susceptible mice (ANOVA,
model: lg.viral.ld ~ suscept; Additional file 4: Table S4
and Additional file 5: Table S5).
Each CC founder strain exhibits a characteristic leukocyte
profile in peripheral blood
The changes in cellular composition of the peripheral blood
after infection was monitored via VetScan hematological
assay (Fig. 6). After infection, the percentage of lympho-
cytes in all strains decreased, whereby the percentage of
granulocytes increased. Only the highly resistant strains
NZO/HlLtJ and PWK/PhJ showed nearly constant levels of
both cell types. The percentage of monocytes was similar
for all strains. Comparison between the eight founder
strains revealed a high percentage of granulocytes in A/J,
129S1/SvImJ, NOD/ShiLtJ and WSB/EiJ on day 3 and 5
after infection, resulting in a ratio of about 35 % of the leu-
kocytes. C57BL/6J, NZO/HlLtJ, CAST/EiJ and PWK/PhJ
exhibited low levels of granulocytes at day 3, 5 and 8 after
infection (20 % or below). CAST/EiJ was the only suscep-
tible strain showing a decrease from day 3 to day 5. Not-
ably, granulocyte amounts in mock infected NOD/ShiLtJ
mice were at 18 % of total WBCs in mock infection. In con-
clusion, CAST/EiJ, although carrying high viral loads in the
lung, exhibited only very low granulocyte counts in the
periphery.
Correlation analysis of phenotypic traits
In our study, we measured changes of several phenotypic
traits (body weight, hematology, relative lung weight,
viral load) in single mice after infection. This allowed us
to correlate these different traits within each subset.
Fig. 7a shows the correlation analysis of body weight
loss, viral load and percentages of cell populations in the
peripheral blood for setup 2 (Table 2). Fig. 7b illustrates
the correlation between body weight loss, relative lung
weight and percentages of cell populations in the periph-
eral blood for setup 3 (Table 2). The analysis showed a
strong negative correlation (coefficients of –0.98 and –
0.97) between percentages of lymphocytes and granulo-
cytes for both subsets which suggests that the main
change in peripheral blood cell composition was mainly
due to an increase in granulocytes (Fig. 7a, b). Further-
more, we found a strong negative correlation (coefficient
of −0.87) between body weight loss and relative lung
weight which suggests that the loss in body weight may
serve as a surrogate for pathological changes in the lung
(edema and immune cell infiltrates) (Fig. 7b). Body
weight loss and percentage of lymphocytes appeared
only weakly correlated with viral load (Fig. 7a, b). Simi-
larly, body weight loss and percentage of lymphocytes
were only moderately or weekly correlated (Fig. 7a, b).
Detailed analysis of unique CAST/EiJ phenotype by flow
cytometry
CAST/EiJ mice were highly susceptible to H3N2 infec-
tion and showed a unique combination of high viral load
in the lungs (Fig. 5) but low granulocyte counts in the
periphery (Fig. 6). Therefore, a more detailed investiga-
tion of the CAST/EiJ mice in comparison to two inter-
mediate susceptible mouse strains was performed by
flow cytometry of blood and lung cells at day 3 and 5
p.i.. We chose C57BL/6J and 129S1/SvImJ mice for this
comparison because 129S1/SvImJ mice exhibited a very
strong response whereas C57BL/6J showed an inter-
mediate peripheral response.
In blood, all three strains had comparable numbers of
granulocytes (Ly6G+CD11b+ cells) before infection
(Fig. 8a). At day 3 p.i., the absolute cell numbers of gran-
ulocytes increased in all strains, but much less in CAST/
EiJ (1.5-fold) compared to C57BL/6J and 129S1/SvImJ
mice (5-and 3-fold, respectively) (Fig. 8a). Furthermore,
granulocyte counts significantly decreased from day 3 to
day 5 in CAST/EiJ (Fig. 8a) but were similar to day 3 in
the other two strains (Fig. 8a). After infection, monocyte
(CD115+ cells) numbers remained high in CAST/EiJ
mice at day 5 p.i., whereas they decreased in the other
two strains from day 3 to day 5 p.i. (although not statis-
tically significant) (Fig. 8a). Furthermore, NK cell
(NKP46+ cells) numbers were lower in non-infected and
at day 3 p.i. in CAST/EiJ compared to C57BL/6J and
129S1/SvImJ mice and at similar levels in CAST/EiJ
mice compared to the other two strains on day 5 p.i.
(Fig. 8a). Also, CAST/EiJ mice exhibited the highest ab-
solute numbers of B cells (CD19+) in non-infected ani-
mals which strongly decreased after infection (Fig. 8a).
CAST/EiJ mice also had low numbers of T-helper (CD4+
cells) and cytotoxic cells (CD8+ cells) compared to
C57BL/6 J and 129S1/SvImJ before and after infection
(Fig. 8a). Both T-cell populations diminished significantly
in CAST/EiJ mice on day 3. In summary, the numbers
of granulocytes in the blood were lower after infection
in CAST/EiJ mice compared to the other two strains
Table 1 ANOVA-Broad-sense heritability and sex effect per day
Days p.i. Heritability H2 Sex effect P-value sex effect
day1 0.28 ns ns
day2 0.39 ns ns
day3 0.28 0.08 1.91e-05
day4 0.45 0.08 6.38e-07
day5 0.58 0.06 3.03e-06
day6 0.59 0.06 4.13e-07
day7 0.65 0.04 2.9e-05
ns: not significant, H2 broadsense heritability, Sex effect sum of squares for sex
divided by total sum of squares using two-way ANOVA model: BWL ~ strain *
sex for each day separately
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Fig. 4 (See legend on next page.)
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whereas the number of monocytes stayed high in the
blood of CAST/EiJ mice.
The most remarkable difference that we observed in
flow cytometry analysis of the lungs from infected
CAST/EiJ mice (Fig. 8b) was the very low number of all
investigated immune cell populations compared to
C57BL/6 J and 129S1/SvImJ mice: granulocytes (Ly6G+
cells), dendritic cells (CD11c+cells), T cells (CD4+ and
CD8+ cells), and macrophages (F4/80+ cells). Granulo-
cytes in CAST/EiJ mice increased by 4-fold from day 0
to 3 p.i. with no further increase from day 3 to 5 p.i.. In
contrast, granulocyte numbers in the lungs of 129S1/
SvImJ and C57BL/6 J increased considerably from day 3
to day 5 p.i. and were 30-times higher on day 5 p.i. com-
pared to CAST/EiJ. The number of macrophages was
generally higher in 129S1/SvImJ and C57BL/6 J lungs
compared to CAST/EiJ mice. However, the increase in
macrophage numbers was much higher in CAST/EiJ
(25-fold from day 0 to day 5) in comparison to 129S1/
SvImJ and C57BL/6 J lungs (4-and 8-fold, respectively).
The amount of dendritic cells (CD11c+) decreased simi-
larly in all three strains after infection. CD4+ (T helper)
cells as well as CD8+ (cytotoxic T) cells decreased until
day 3 p.i. and then significantly increased until day 5 p.i.
in all three strains. In summary, CAST/EiJ mice exhib-
ited in general much lower numbers of immune cells in
the lungs before and after infection. After infection,
granulocyte numbers increased much less in CAST/EiJ
lungs compared to the other two strains whereas the
relative increase in macrophages was higher in CAST/
EiJ.
Histopathological and immunohistochemical studies of
lungs revealed differences in lung pathology of CAST/EiJ
mice in comparison to C57BL/6J and 129S1/SvImJ
We investigated the lungs of CAST/EiJ mice in compari-
son to C57BL/6J and 129S1/SvImJ mice by histopath-
ology and immunohistochemistry at different days after
infection. C57BL/6J, 129S1/SvImJ and CAST/EiJ mice
developed a multifocal mild to severe necrotizing and/or
granulocytic broncho-interstitial pneumonia (Fig. 9,
Table 3). In C57BL/6J mice at 3 day p.i., the alveolar
septa were mildly thickened with infiltration of few
granulocytes and there was mild to moderate necrosis
of alveolar, bronchiolar and bronchial epithelial cells.
In the alveolar, bronchiolar and bronchial lumina there
were moderate inflammatory infiltrates consisting of
granulocytes, increased numbers of alveolar macrophages,
small amounts of proteinaceous material (edema) and fi-
brin, and mild hemorrhage (Table 3). Peribronchiolarly,
peribronchially and perivascularly there was moderate
edema and infiltration of moderate numbers of granulo-
cytes and fewer macrophages, lymphocytes and plasma
cells. At day 5 p.i., there was an increase in numbers of in-
flammatory cells in the alveolar lumina and amounts of
intraalveolar edema and hemorrhage. Also, there was
more alveolar and bronchiolar epithelial necrosis and
pneumocyte type II hyperplasia. At day 8 p.i., in addition
to previously described changes, there were intra-alveolar
hyaline membranes and flattening of bronchiolar and
bronchial epithelium. In C57BL/6J mock infected mice no
significant lesions were observed. Lungs of 129S1/SvImJ
mice showed less granulocyte infiltration and type II
pneumocyte hyperplasia in the alveoli, less peribronchio-
lar, peribronchial, and perivascular infiltration, but slightly
more necrosis of alveolar, bronchiolar and bronchial epi-
thelium (Table 3). In lungs of CAST/EiJ mice we observed
lower numbers of granulocytes and mild or no peri-
bronchiolar, peribronchial and perivascular infiltrates.
There was a trend for fewer intra-alveolar granulocytes
and more intra-alveolar macrophages in CAST/EiJ mice
compared to C57BL/6J and 129S1/SvImJ mice at day 5 p.i.
(Additional file 6: Table S6). These observations were con-
sistent with the flow cytometry data (Fig. 8) showing that
CAST/EiJ mice exhibited an increase in granulocytes,
macrophages and T lymphocytes whereas the absolute
amount of leukocytes remained very low compared to the
other susceptible strains. Immunohistochemistry showed
that influenza virus antigen was present in respiratory epi-
thelial cells of all strains (Fig. 9, Table 3). The number of
positive alveolar epithelial cells peaked at 5 days p.i. in all
strains, with about twice as many positive cells in the
CAST/EiJ mice as in C57BL/6J or 129S1/SvImJ mice. The
number of positive bronchiolar and bronchial epithelial
cells was higher in CAST/EiJ mice (day 3 and 5 p.i.) than
in C57BL/6J and 129S1/SvImJ mice. This observation re-
vealed that cellular distribution of virus and number of in-
fected cells was different in CAST/EiJ lungs compared to
the other highly susceptible strains although the total viral
load was similar (Fig. 5). This can be explained by the fact
that CAST/EiJ lungs are smaller in comparison to the
other analyzed strains. Thus, similar total amounts of in-
fectious virus (viral load) in the lung of CAST/EiJ mice
would result in a higher number of infected cells. In mock
(See figure on previous page.)
Fig. 4 Increase in relative lung weight after influenza A H3N2 infection. Eight to twelve weeks old female mice of the eight CC founder strains
were infected intra-nasally with 1 × 101 FFU of the mouse-adapted influenza H3N2 virus (A/HK/01/68). Lung weight was determined on day 3, 5,
8, 18 and 30 p.i. and for mock infected animals on day 3 post PBS treatment. CC founder strains showed comparable increase in relative lung
weight up to 2 % except for the highly resistant NZO/HlLtJ and PWK/PhJ. Each data point represents the measurement of one animal. Additionally, the
mean and the standard error of the mean are shown for each time point and strain
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Fig. 5 Constant high viral load in highly and intermediate susceptible and viral clearance in resistant strains. Eight to twelve weeks old female
mice of the eight CC founder strains were infected intra-nasally with 1 × 101 FFU of influenza H3N2 virus. Lung samples were taken for mock
infected animals on day 3 post treatment and on day 3, 5, and 8 p.i.. Lungs of mice of all CC founder strains showed comparable high viral loads
at 105 FFU/lung from day 3 until day 5 p.i.. NZO/HlLtJ and PWK/PhJ had lower viral loads and cleared virus until day 8 p.i.. Each data point represents
the measurement of one animal; mean and standard error of the mean are shown for each time point and strain
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Fig. 6 Mice of each founder strain showed a characteristic leukocyte profile in peripheral blood. Blood samples were taken from the same
animals used for viral load analysis (Fig. 5) and analyzed regarding granulocyte (green), lymphocyte (red) and monocyte (blue) amounts displayed as
percentage of white blood cells (WBCs)
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Fig. 7 Correlation analysis of phenotypic traits. Correlation analysis of phenotypic traits from setup 2 (a) and setup 3 (b). The diagonal represents
the histogram of the measured values from a given trait, the bottom left panel represents scatter plots of pairs of phenotypic measurements, the
top right panel shows correlation coefficients and p-values from a linear regression analysis. Values for days 3, 5, 8 and 18 p.i. (n = 41, 47, 38, and
1, respectively) were combined. BW: percent body weight, re_lung_wght: relative lung weight (in reference to body weight at time of sacrifice),
WBC: weight blood cells (109 cells per l), lympho_perc: percent lymphocytes (of total white blood cells), mono_perc: percent monocytes (of total
white blood cells), granu_perc: percent granulocytes (of total white blood cells), lg.virl.ld: log2 viral load per lung. n = 127 for subset 2, n = 173 for
subset 3. **: p-value <0.01, ***: p-value < 0.001
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infected mice no virus antigen was detected in any tissue
examined.
Analysis of global gene expression changes in lung and
blood of CAST/EiJ mice revealed abnormal immune
response after infection
To further investigate the high susceptibility of CAST/
EiJ mice and to gain insights into the gene regulatory
networks involved, we infected female CAST/EiJ,
C57BL/6J, 129S1/SvlmJ and PWK/PhJ mice with 1 × 101
FFU H3N2 virus and performed transcriptome analysis
of the lungs and peripheral blood at 3 and 5 days p.i.
and mock day 3. Principal component analysis (PCA) of
all individual samples from the lungs revealed good
grouping of biological replicates and a clear separation
of infected versus mock-infected mice (Fig. 10a). The
first principal component reflected expression changes
associated with disease whereas the second principal
component was driven by mouse subspecies. C57BL/6J
and 129S1/SvlmJ exhibited a change in gene expression
from mock-infected to infected lungs at day 3 to day 5
p.i.. Also, CAST/EiJ infected mice did show a strong
change from mock-to influenza infected samples. How-
ever, samples from days 3 and 5 p.i. were not separated
from each other in CAST/EiJ mice in contrast to the
changes in C57BL/6J and 129S1/SvlmJ. These observa-
tions indicate a strong peak inflammatory response
already at day 3 p.i. in infected CAST/EiJ mice. PWK/
PhJ mice exhibited a shift from mock-infected mice to
day 3 and day 5 p.i. whereby the distance to mock-
treated mice was larger at day 3 than at day 5 suggesting
that the low replication rate of influenza virus in the
lungs of PWK/PhJ mice induced a much lower inflam-
matory response which was already partly resolved at
day 5 p.i.. Identification of differentially expressed probe
sets (DEPS, showing a 2-fold or more absolute difference
in expression compared to mock-treated mice with an
adjusted p-value of < 0.05) revealed highest number of
DEPS for infected versus mock-infected CAST/EiJ mice
on day 3 (2054) and day 5 p.i. (2513), respectively
(Fig. 11). C57BL/6J infected mice had intermediate num-
bers of DEPS that were at similar levels on day 3 p.i.
(966 and 975, respectively) and higher in 129S1/SvlmJ
(1627) than in C57BL/6J (1108), respectively, at day 5
p.i.. Lowest number of DEPS were observed for PWK/
PhJ for both days, exhibiting higher numbers on day 3
(604) compared to day 5 p.i. (306). These results corrob-
orate the conclusions above from the PCA analysis. Ana-
lysis of 13 inflammatory genes that are strongly
regulated in influenza infected mice [35] revealed that
all infected mice exhibited a similar level of up-
regulation confirming that all mice were successfully in-
fected. In addition, these results showed that CAST/EiJ
mice were able to initiate a proper inflammatory host re-
sponse (Additional file 7: Figure S1).
For the PCA of the blood transcriptomes, we first per-
formed an ANOVA analysis and selected probe sets that
were significantly regulated (p < 0.001). The resulting
PCA of these 2079 probe sets revealed good grouping of
infected and non-infected groups as well as for the dif-
ferent strains (Fig. 10b). Analysis of 13 inflammatory
genes [35] showed similar up-regulation of the inflam-
matory response in CAST/EiJ mice compared to 129S1/
SvlmJ and C57BL/6J. PWK/PhJ mice exhibited only
weak up-regulation or even down-regulation of these
genes (Additional file 8: Figure S2). The results again
show that CAST/EiJ mice were capable to initiate a
proper inflammatory response at the transcriptional level
in the blood.
We also performed a Digital Cell Quantification
(DCQ, [36]) to investigate possible differences in im-
mune cell populations of CAST/EiJ mice. DCQ of blood
from infected CAST/EiJ mice revealed lower numbers of
granulocytes and a higher number of monocytes and
macrophages compared to infected 129S1/SvlmJ mice
(Fig. 12a). DCQ analysis of the lung transcriptome
showed equal numbers of monocytes and macrophages
in CAST/EiJ and 129S1/SvlmJ mice and a much stronger
reduction in dendritic cells in CAST/EiJ compared to
129S1/SvlmJ mice after infection (Fig. 12b).
To identify genes that may be involved in the high sus-
ceptibility in CAST/EiJ mice, we determined probe sets
that were up-regulated in the lungs of C57BL/6J and
129S1/SvlmJ at days 3 and 5 p.i. compared to the mock
control but not in CAST/EiJ. However, it should be
noted that differences in expression signals from array
analysis of the genetically diverse CC mice may also be
caused by SNPs in probes. We therefore confirmed ex-
pression changes obtained from an array data set with
expression changes observed by RNAseq [31]. Only
those genes were retained that were differentially regu-
lated in both, our arrays and the RNAseq study. The fil-
tering revealed eight genes that failed to be up-regulated
in CAST/EiJ mice (Fig. 13): Prm1 (protamine 1), Gdf3
(growth differentiation factor 3), Nts (neurotensin),
Plekhs1 (pleckstrin homology domain containing, family
S member 1), Hpse (heparanase), F830016B08Rik
(RIKEN cDNA F830016B08 gene), Insrr (insulin
receptor-related receptor), Wfdc17 (WAP four-disulfide
core domain 17). In addition, the analysis of the
Table 2 Experimental setups
Setup Body weight Viral load Hematology Relative lung weight
1 + - - -
2 + + + -
3 + + +
Three different experimental setups with combination of different
phenotyping parameters were used
Leist et al. BMC Genomics  (2016) 17:143 Page 13 of 30
Fig. 8 (See legend on next page.)
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chemokine/cytokine KEGG pathway showed a strong
down-regulation of Ccr6 (chemokine (C-C motif ) recep-
tor 6) specifically in CAST/EiJ mice (Fig. 14).
We subsequently investigated other genes involved in
the regulatory networks of Hpse and Ccr6 (see discus-
sion) and found specific gene expression changes of
Ccr7 (chemokine (C-C motif ) receptor 7), Cxcr5 (che-
mokine (C-X-C motif ) receptor 5), Cxcr1 (chemokine
(C-X-C motif ) receptor 1), and Hspg2 (perlecan, heparan
sulfate proteoglycan 2) in CAST/EiJ mice after infection
(Fig. 14).
We also filtered for genes that were up-regulated in
the blood of C57BL/6J and 129S1/SvlmJ at days 3 and 5
p.i. but not in CAST/EiJ and found four DEPS: Il1b
(interleukin 1 beta), Pi16 (peptidase inhibitor 16) and
I830012O16Rik (RIKEN cDNA I830012O16 gene). The
Fig. 9 Histopathology and immunohistochemistry of C57BL/6J, 129S1/SvImJ and CAST/EiJ lungs five days after H3N2 infection. The lesions in the
lungs of the C57BL/6J and 129S1/SvImJ mice were more extensive than in the CAST/EiJ mice (top row, HE 4× objective) with more severe
bronchiolar epithelial necrosis and peribronchiolar inflammatory infiltrates (second row, HE 20× objective), more severe inflammatory infiltrates in the
alveoli (third row, HE 40× objective) and more cells with presence of virus antigen by immunohistochemistry (bottom row, IHC 40× objective)
(See figure on previous page.)
Fig. 8 Flow cytometry analysis of immune cells in blood and lungs. Blood samples and lungs from infected C57BL/6J (grey bars), CAST/EiJ (green
bars) and 129S1/SvImJ (pink bars) mice (1 × 101 FFU) were prepared. Cell suspensions were analyzed by flow cytometry on days 0, 3 and 5 p.i..
After excluding dead cells fluorochrome-labeled antibodies were used to differentiate various immune cell populations in blood (a) and lungs (b):
CD4pos (T helper cells); CD8pos (cytotoxic cells); CD19pos (B cells), NKp46pos (NK cells), CD11b pos Ly6Gpos (granulocytes), CD115pos (monocytes) and
F4/80pos (macrophages). The number of individual cell populations over time (mean +/−SEM) was determined. For each measurement lungs and
blood samples from individual animals were used. Data from two independent experiments were combined (n = 6 per time point). Data of different
time points were analyzed for statistically significant differences using non-parametric Mann–Whitney-U-test (*: p-value ≤ 0.05; **: p-value ≤ 0.01)
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Table 3 Average scoring of lesions by histopathology and of virus antigen expression by immunohistochemistry in lung tissue of C57BL/6 J, 129S1/SvImJ and CAST/EiJ mice
infected with H3N2
Histopathology score IHC score
Strain Day post
infection or mock
control
Extent
alveolitis/alveolar
damage
Severity of
alveolitis
Severity of
alveolar edema
Presence of
interstitial edema
Presence of type
II pneumocyte
hyperplasia
Severity of
bronchiolitis/
bronchitis
Degree of
peribronchial/
perivascular
cuffing
Alveoli Bronchioles
and bronchi
C57BL/6J mock d3 0 0 0 1.0 0 0 0 0 0
d3 1.7 2.0 0.3 1.0 0.7 2.7 1.7 7.0 1.0
d5 2.0 3.0 1.0 1.0 0.3 2.3 2.0 9.7 1.3
d8 3.0 3.0 1.0 1.0 1.0 2.3 1.7 3.0 1.7
129S1/SvImJ mock d3 1.3 1.0 0 0 0 0 0 0 0
d3 1.7 2.0 0.3 0.7 0 1.7 1.3 4 0.3
d5 1.7 2.3 1.0 1.0 0.3 3.0 2.0 10.7 1.3
d8 3.0 3.0 1.0 1.0 1.0 2.7 2.0 10.3 2.0
CAST/EiJ mock d3 0.3 0.3 0 0 0 0 0 0 0
d3 1.7 1.7 0.7 1.0 0.3 1.0 0.7 12 1.3
d5 2.7 1.7 1.0 1.0 1.0 1.0 1.0 18.7 1.3
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fourth probe set belonged to a gene from which a sec-
ond probe set was not lower in CAST/EiJ mice and it
was therefore omitted (Additional file 9: Figure S3).
Discussion
Here, we have analyzed various phenotypic traits after
influence A (H3N2) infection in the CC founder strains.
We found a strong influence of genetic variation on all
traits and a large variation of the host response and
pathology. In particular, the response in CAST/EiJ mice
revealed a unique phenotype which may represent a new
model for the human leucocyte recruitment deficiency
disease.
Susceptibility and resistance to influenza infection and
disease is strongly influenced by genetic variation
Our comprehensive analysis of the CC founder strains
revealed highly variable phenotypes for all investigated
Fig. 10 Principle component analysis of gene expression values from infected lungs and blood. Principle component analysis (PCA) revealed
separate grouping of non-infected mice and infected mice for all mouse strains in the first component as well as separation by mouse subspecies
in the second component. Replicates for a given day p.i. grouped well together. (a) PCA of all probe sets from lungs; (b) PCA of 2079 probe sets
from blood that were significantly regulated (p < 0.001). Proportion of variances for lung: PC1: 29 %, PC2: 21 %, PC3: 13 %. Proportion of variances
for blood: PC1: 37 %, PC2: 16 %, PC3: 11 %
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Fig. 11 Differentially expressed probe sets. The number of differentially expressed probe sets (DEPS) exhibiting a log2-fold change of >1 and an
adjusted p-value of < 0.05 were determined by LIMMA between infected and non-infected groups for days 3 and 5 p.i.. Up-regulated DEPS are
shown in blue, down-regulated in red
Fig. 12 DCQ analysis of gene expression changes in blood and lung. Changes in relative numbers of immune cells were determined by DCQ for
each mouse in blood (a) and in lung (b) based on changes in gene expression levels. Results from the analysis were visualized as heat maps for
217 immune cell populations that are available in the database at the DCQ server (http://dcq.tau.ac.il/). Changes in cell populations that were
specific for CAST/EiJ mice are shown. The detailed description of individual cell populations is provided in Additional file 11: Table S7
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traits (Fig. 15). On the basis of mortality rate, MTTD,
and body weight changes, we could distinguish three dif-
ferent susceptibility groups: highly susceptible strains,
intermediate susceptible strains, and highly resistant
strains. Amongst the resistant strains, NZO/HlLtJ only
marginally lost weight (less than 10 %) at the low infec-
tion dose but exhibited weight loss at the higher doses
whereas PWK/PhJ mice also exhibited a larger loss of
body weight early after infection.
In previous studies, CC founders and incipient lines of
the CC had been studied after infection with H1N1 (A/
PR/8/34 (PR8)) virus and the authors described a large
variation on phenotypes [34, 37]. Here, we investigated
the CC founder strains after infection with another con-
temporary influenza virus subtype, H3N2 (A/HK/01/68),
and we also observed high diversity of phenotypic re-
sponses between the founder strains. The study by Ferris
et al., phenotyped infected mice only until day 4 p.i.
Fig. 13 Changes in the expression levels of probe sets that were up-regulated in 129S1/SvImJ and C56BL/6J but not in CAST/EiJ mice. Expression
values represent normalized log2 transformed signal intensities in the lungs of infected mice at different time points p.i. relative to expression
levels in mock-infected control mice
Fig. 14 Changes in the expression levels of probe sets that corresponded to genes of the CCR6 regulation network. Expression values represent
normalized log2 transformed signal intensities in the lungs of infected mice at different time points p.i. relative to expression levels in mock-
infected control mice
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[34]. They identified a highly susceptible and a highly re-
sistant group. Similarly, Bottomly and colleagues
categorize a severe and mild response to infection based
on global transcriptome profiling [37]. In our studies, we
monitored the infected mice over a much larger period,
14 days p.i., and also performed infections with different
doses of the same virus, and we distinguish three sus-
ceptibility groups. Analysis of variance (ANOVA) for
body weight changes revealed that the factor strain had
the strongest effect on body weight loss indicating high
heritability for this trait. These results thus demonstrate
that CC founder strains and CC strains will represent a
highly valuable model system to identify genetic factors
that regulate susceptibility to infections and other host
responses. Indeed, in an analysis of incipient pre-CC
strains, several chromosomal regions were identified that
influence gene expression of the host response as well as
pathology in the lung [34, 37].
Influence of sex on disease progression and outcome
Using ANOVA, we also found that sex had also a signifi-
cant effect on body weight loss. At a dose of 1 × 101 FFU
female mice exhibited higher body weight loss compared
to males. However, the effect of sex was weaker than the
strain effect. The influence of sex had not been reported
in previous studies which were performed only in fe-
males [34, 37]. In pairwise comparisons of strains, we
found significant sex-specific differences in body weight
loss in the highly and intermediate susceptible group
after infection with 1 × 101 FFU, but not in the highly re-
sistant group. Differential responses to H3N2 influenza
A infections between female and male mice have been
reported previously [38, 39]. Also sex-specific differences
to influenza A virus infections in humans have been ob-
served. However, the present knowledge is rather limited
because epidemiological data often lack information on
sex. Furthermore, tendencies showing that either females
or males are more prone to severe disease progression
are influenced by additional factors like general life style,
social behavior, coinfections or viral exposure (reviewed
in: [40]). Our results suggest that influenza infections in
the CC population may represent a highly valuable re-
source to obtain a better understanding of sex-specific
responses to pathogens in mammals, including humans.
We did not observe significant differences in survival
between male and female mice in the founder stains, ex-
cept for NOD/ShiLtJ. NOD/ShiLtJ mice spontaneously
develop insulin-dependent type 1 diabetes mellitus
(T1D) which is characterized by the destruction of pan-
creatic cells [41, 42]. They also show several abnormal-
ities in immune cells, like defective antigen presentation
[43], abnormalities in T [44] and NK cells [45] as well as
impaired cytokine signaling in macrophages [46]. Female
NOD/ShiLtJ mice exhibit a strong decrease in insulin
production already at the age of 12 weeks, which starts
several weeks later in males. The incidence of spontan-
eous T1D is much higher in females (60-80 %) compared
to males (20-30 %) [41]. Thus, the increased susceptibil-
ity to influenza A infections in females which we ob-
served may be directly related to their pre-diabetic/
diabetic state or to an abnormal immune response. It
has been shown, that there was an increased risk of
complications among patients with diabetes after
pH1N1 infection [47]. Therefore, NOD/ShiLtJ mice may
provide a valuable mouse model for investigating the
role of diabetic state on influenza A infections.
Different Mx1 alleles influence survival rates and viral
load but are modulated by host genetic background
Many studies on influenza pathogenesis in mice were
performed in classical laboratory strains which carry a
mutation in the influenza resistance gene Mx1 first de-
scribed in the A2G mouse strain [48]. The CC founder
strains carry five different Mx1 alleles ([34], Fig. 16). The
Fig. 15 Phenotyping the CC founder strains after influenza A H3N2 infection. The eight CC founder strains were classified into three different
subgroups (highly resistant, intermediate susceptible and highly susceptible) according to their outcome after 1 × 101 FFU influenza A H3N2 infection.
They showed high variation in changes in body weight, viral loads in lungs, hematological parameters in peripheral blood and relative lung weight
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amino acid sequences of the protein encoded by the
Mx1 alleles in NZO/HlLtJ and A2G were identical to the
consensus sequence from the multiple alignments. The
PWK/PhJ allele encodes one and the CAST/EiJ allele
two amino acid changes compared to the consensus se-
quence. The WSB/EiJ transcript of Mx1 harbors a stop
codon in its open reading frame leading to a truncated
protein. All classical laboratory strains (A/J, C57BL/6J,
129S1/SvImJ and NOD/ShiLtJ) carry a deletion from the
8th to the 12th exon, resulting in a protein that has pre-
viously been shown to be non-functional [34, 49]. In our
study, the presence or absence of a functional Mx1 allele
correlated strongly with resistance and susceptibility.
PWK/PhJ and NZO/HlLtJ were highly resistant and sur-
vived a virus challenge with increasing doses of infec-
tion, 1 × 101 FFU, 2 × 103 FFU and 2 × 105 FFU. Thus,
the single amino acid difference had no influence on the
protective functions of the MX1 protein. In contrast, the
amino acid exchanges in the CAST/EiJ protein seemed
to be detrimental leading to a highly susceptible pheno-
type. Similar results were obtained after infection with
H1N1 (A/PR/8/34 (PR8)) virus [34]. We recently found
that the protective function of MX1 is dependent on
genetic back ground [50]. Thus, further experiments are
needed to elucidate the function of the CAST/EiJ MX1
protein and the potential contribution of the CAST/EiJ
genetic background.
MX1 is known to inhibit IAV replication [51, 52].
Therefore, we investigated viral load at different time
points p.i. in the CC founder stains and related to the
absence or presence of a functional Mx1 allele. Viral
load was lowest in PWK/PhJ mice, was only detected at
early times p.i. and was cleared by day 8 p.i.. NZO/HlLtJ
mice were also able to clear the virus, but viral titer in-
creased until day 5. Thus, there is a clear difference in
viral load even in strains that carry a functional Mx1 al-
lele which may be caused by genes that modulate the ac-
tivity of MX1 or other immune response genes. In
contrast, all intermediate and highly susceptible mice
strains that carried the non-functional Mx1 alleles exhib-
ited high viral loads already on day 3, and virus was not
cleared on day 8 or at the time of death. The CC popula-
tion now offers the possibility of investigating the same
Mx1 allele on different genetic backgrounds and to iden-
tify potential modifying loci that interact with MX1.
Correlation of viral load with other phenotypes
We did not observe a general correlation between viral
load and survival in the susceptible strains. All suscep-
tible and intermediate susceptible strains had similar
viral loads. For other mouse strains it had been shown
that high viral loads in the lung correlate well with in-
creased susceptibility to IAV. For example, the highly
susceptible DBA/2 J strain exhibited a higher viral load
compared to resistant C57BL/6J mice [53, 54]. Boon et
al. [55] studied viral load in 21 inbred mouse laboratory
strains infected with H5N1 (A/HK/213/03). They found
significant association of viral load and mortality
whereby an increased host inflammatory response was
caused by a higher viral load. However, other studies
demonstrate no differences in viral load between resist-
ant and susceptible strains [56]. Ferris et al. concluded
Fig. 16 Mx1 sequence alignment of A2G and the eight CC founder strains. Mx1 alleles of CC founder strains in comparison to the A2J allele are
shown. The mouse Mx1 gene has 14 exons (blue). Changes of the nucleotide sequence in exons (yellow) result in amino acid exchanges indicated below
by showing the respective amino acid exchange. PWK/PhJ exhibits one amino acid exchange relative to A2J, CAST/EiJ two changes at different positions.
A premature stop codon is present in WSB/EiJ leading to a truncated MX1 protein. The other strains (A/J, C56BL/6J, 129S1/SvImJ and NOD/ShiLtJ) possess
a deletion between the 8th and the 12th exon resulting in a non-functional protein. The graph was created based on data from ncbi.com and [34]
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from studies of pre-CC mice that both viral replication
and virus-induced inflammation were predictors for dis-
ease severity being independent of each other. Neverthe-
less, when both were combined they were better
predictors than either of them alone [34]. Thus, in con-
clusion, either increased viral load causing extensive tis-
sue damage or a hyper-inflammatory host response may
result in a lethal outcome of an influenza infection.
Therefore, the analysis of the divergent host responses
in CC mice will allow investigating the biological mecha-
nisms and the cellular and molecular networks in detail
in a controlled experimental system and thus substan-
tially contribute to better understand individual host fac-
tors that are involved in causing severe influenza disease
outcomes in humans.
CAST/EiJ mice exhibit a distinct deficiency in their
immune response to influenza infections
Hematological analysis of the peripheral blood in in-
fected CAST/EiJ mice showed only a slight increase in
granulocytes in the peripheral blood compared to other
strains that had high viral loads in their lungs. Thus, we
hypothesized that CAST/EiJ may exhibit a specific defi-
ciency in their response to influenza infection. We there-
fore studied the immune response in CAST/EiJ mice in
more detail by analyzing immune cells in blood and lung
in comparison to other strains. Flow cytometry studies
revealed that the increase of granulocytes in the blood
was much lower after infection in CAST/EiJ mice com-
pared to the other two strains whereas the number of
monocytes stayed high in the blood of CAST/EiJ mice.
In the lung, CAST/EiJ mice exhibited an increase of
granulocytes, macrophages and T lymphocytes. How-
ever, the absolute amount of leukocytes remained very
low compared to the other susceptible strains. After in-
fection, granulocyte numbers increased much less in
CAST/EiJ lungs compared to the other two strains
whereas the relative increase in macrophages was higher
in CAST/EiJ. Histological analysis confirmed the low
level of neutrophil infiltrations in the lung and increased
macrophage numbers. Also, DCQ analysis of global gene
expression changes confirmed the low neutrophil re-
sponse in the blood, reduced neutrophil infiltration into
the lung and an increase in macrophage numbers in the
lung. In line with our results, Ferris et al. showed that
CAST/EiJ mice developed high viral loads in lungs after
influenza infection but showed less infiltrating immune
cells in their lungs [34]. They and others observed low
levels of T and NK cells in the blood of CAST/EiJ mice
[34, 57]. CAST/EiJ mice are also highly susceptible to
monkeypox virus (MPXV) infection lacking interferon
gamma (IFN-γ) induction which might be related to a
defect in activation and recruitment of IFN-γ producing
immune cells [58]. CAST/EiJ mice were rescued from le-
thal challenge with MPXV by intra-nasal administration
of IFNγ [58]. However, IFNγ is not crucial for the host
response to influenza infection [59] whereas, interferons
type I and III are essential [60–62]. Therefore, we inves-
tigated if pre-treatment with IFN-I was able to rescue
CAST/EiJ mice from lethal influenza A infection. We
observed a shift of about two to three days in the sur-
vival curve for IFN-treated versus non-treated CAST/EiJ
mice. However, IFN pre-treatment did not rescue
CAST/EiJ mice from lethal infection (data not shown).
In addition, we did not observe reduced levels of Ifng
transcripts in CAST/EiJ compared to the other mouse
strains (Additional file 7: Figure S1 and Additional file 8:
Figure S2).
Our observations suggest that granulocytes have a defi-
ciency to enter the site of infection in CAST/EiJ mice.
Members of the CXC chemokine family, notably CCL4
and CCL5, as well as selectins, play a major role in the re-
cruitment of leukocytes, especially of neutrophils [63]. We
showed earlier that genes from these two families, notably
CXC chemokines, are upregulated very early after influ-
enza infection in lungs of C57BL/6J mice [35]. However,
we observed that after infection the transcript levels of
Ccl4 and Ccl5 were similarly up-regulated in the lungs of
CAST/EiJ as for 129S1/SvImJ and C57BL/6J (data not
shown). Also, deficiencies in several CXC chemokine
ligands and receptors (Cxcr2, Cxcl10, Cxcr3, Cxcl5) dimin-
ish the leukocytes influx into lungs [64–67]. The
expression of Cxcl10, Cxcr3 and Cxcl5 was not differently
regulated in CAST/EiJ compared to the two other suscep-
tible mouse strains (data not shown). However, expression
of Cxcr2 dropped to base line levels at day 5 p.i. only in
CAST/EiJ mice (data not shown). It was reported for vari-
ous inflammation models that in mice deficient in E-, L-,
or P-selectin genes (Sele, Sell, Selp), the levels of neutro-
phils, T lymphocytes and lung inflammation are reduced
[68–72]. All selectin genes were similarly up-regulated in
all three susceptible genes in the lung after infection.
However, Sele was strongly down-regulated in CAST/EiJ
on day 5 p.i. (Additional file 10: Figure S4). Furthermore,
the continuous recruitment of leukocytes is regulated by a
feed-forward loop in which infiltrated immune cells in the
lung enhance the release of chemokines leading to the re-
cruitment of more neutrophils [73]. The depletion of neu-
trophils resulted in uncontrolled virus growth and
increased mortality in mice [74]. Thus, reduced granulo-
cyte infiltration in CAST/EiJ may secondarily also affect
the subsequent recruitment of more granulocytes and
other immune cells. However, we do observe an increase
in macrophages. Further analyses will be necessary to
unravel the details of these interactions phenomenon.
In summary, the amount of granulocytes in the blood of
CAST/EiJ mice increased after infection which suggests a
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normal primary signaling of infected cells to the
hematopoietic system and the release of leukocytes into
the blood. However, the number of granulocytes remained
constant in the lungs of CAST/EiJ from day 3 on and did
not further increase. In contrast, granulocyte numbers
strongly increased in lungs of 129S1/SvImJ and C57BL/6J
mice. The strong specific down-regulation of Sele at day 5
supports the hypothesis of a leukocyte recruitment defi-
ciency in CAST/EiJ mice. Together, these results suggest
that the lack of sustained neutrophil recruitment may be
the primary defect in CAST/EiJ mice.
We also performed a more detailed analysis of gene
expression changes at the level of gene interaction path-
ways and individual genes to obtain more insights into the
underlying mechanism of the abnormal CAST/EiJ im-
mune cell phenotype. The canonical inflammatory genes,
interferons and interferon response genes as well as many
inflammatory chemokines such as Cxcl10, are all highly
up-regulated in the lungs of CAST/EiJ mice. In addition,
CAST/EiJ mice showed the highest number of DEPS after
infection in blood and lungs. Thus, CAST/EiJ mice exhib-
ited not a general deficiency in the overall activation of an
inflammatory response but rather a specific defect in the
recruitment of cells to the lung. Seven genes were specific-
ally not up-regulated in CAST/EiJ after infection which
have not been described in the context of the host re-
sponse to influenza infections, but may be also important
host factors for virus defense in humans [14]. Further-
more, the Hpse gene was not as strongly up-regulated
after infection in CAST/EiJ compared to the other mouse
strains. Hpse encodes heparanase, a mammalian endogly-
cosidase which degrades heparan sulfate glycosaminogly-
can in extracellular space and within the cells. It was
postulated that heparanase may play an important role
in inflammatory and autoimmune processes including
leukocyte recruitment, immune cell extravasation and
migration, release of cytokines and chemokines and ac-
tivation of innate immune cells (reviewed in [75, 76]).
Recently, the role of heparanase in regulating the mi-
gration of DCs was demonstrated in heparanase-
deficient mice [77]. When we analyzed the expression
profiles of genes in the heparanase network, we found a
specific down-regulation of the Hspg2 gene in CAST/
EiJ mice. Hspg2 encodes perlecan [78–80] also known
as basement membrane-specific heparan sulfate proteo-
glycan 2 (HSPG2). Perlecan is a large multi-domain
proteoglycan that binds to and cross-links many extra-
cellular matrix (ECM) components and cell-surface
molecules. It is a key component of the vascular extra-
cellular matrix, where it interacts with a variety of other
matrix components helping to maintain the endothelial
barrier function. Three long chains of glycosaminogly-
cans are attached to the perlecan core protein that
plays an important role in the recruitment of leukocytes
via binding to chemokines [81, 82]. Also, the Wfdc17
gene, encoding the AMWAP protein (activated micro-
glia/macrophage whey acid protein domain protein),
was not expressed in CAST/EiJ mice before and after
infection. AMWAP has been postulated to be a nega-
tive regulator of pro-inflammatory microglia/macro-
phage activation and a potential modulator of innate
immunity in neurodegeneration [83]. Interestingly,
Wfdc17 was up-regulated in lungs of C57BL/6J, 129S1/
SvlmJ and PWK/PhJ after infection, but not in CAST/
EiJ which is consistent with the observed increase of in-
filtrating macrophages in CAST/EiJ lungs. In addition,
analysis of the KEGG chemokine/cytokine pathway re-
vealed a strong down-regulation of Ccr6 (chemokine
(C-C motif ) receptor 6) in the lung that was unique for
CAST/EiJ mice. CCR6 is an important chemokine re-
ceptor that mediates recruitment of immature and ma-
ture DCs and antigen presenting cells (APCs) to the
sites of epithelia inflammation in the lung (reviewed in
[84]). Epithelial cells in the lung increase their produc-
tion of CCL20, which is the only chemokine ligand for
CCR6, which in turn causes a further recruitment of
immature CCR6-positive DCs into the lung. Ccr6 ex-
pression is down-regulated during the maturation
process and accordingly Ccr7 is upregulated leading to
the migration of DCs to the lymph node to fulfill its
APC function. The expression of Ccr6 was down-
regulated in all analyzed mouse strains, but very
strongly in CAST/EiJ lungs, especially at day 5 after in-
fection. Interestingly, Ccr7 expression was up-regulated
in all strains, but not in CAST/EiJ, where Ccr7 was
down-regulated. After infection a large number of im-
mature DC continuously enter the lung tissue and then
differentiate into mature DCs [84]. This process was
reflected by the up-regulation of Ccr7 in C57BL/6J and
129S1/SvlmJ. However, in CAST/EiJ mice less imma-
ture DC cells enter the lung which may be reflected by
the decrease of Ccr6 and Ccr7 expression. Another
down-regulated gene in CAST/EiJ was Cxcr1, a mem-
ber of the G-protein-coupled receptor family. CXCR1 is
a receptor for the CXC chemokine interleukin IL-8,
which is a potent neutrophil recruiting [85] and activat-
ing factor [86, 87]. IL-8 is an important modulator of
monocyte-endothelial interactions under flow condi-
tions, since it can rapidly cause rolling monocytes to
adhere firmly onto monolayers expressing E-selectin
[88]. Furthermore, Cxcr5 was down-regulated in
CAST/EiJ lungs but not in the other strains. CXCR5 is
a cytokine receptor that binds to B-lymphocyte attract-
ant (BLC) and is involved in B-cell migration [89, 90].
Filtering for genes that were up-regulated in the
blood of C57BL/6J and 129S1/SvlmJ but not in CAST/
EiJ identified three genes. One of those Il1b (interleu-
kin 1 beta) encodes IL1B which is an important
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inflammatory cytokine that mediates the inflammation
and initiate the immune response against Influenza A
virus infection [82]. Pro-IL-1B is cleaved by caspase-1
which is activated through the formation of the NLRP3
inflammasome [91] and induces the expression of a
variety of inflammatory mediators, which initiate the
cascade of inflammatory responses [92]. It was postu-
lated that the synergy between CD40L and IL-1beta
represents a potent, T cell-independent mechanism for
DC activation during the earliest stages of inflamma-
tory responses [93]. Most interestingly, in humans it
has been described that genetic variants in IL1A and
IL1B contribute to the susceptibility to 2009 H1N1 in-
fections [94].
In summary, the specific changes of gene expression
patters that were unique in CAST/EiJ lungs belong to
gene networks that play a crucial role in migration and
recruiting of leukocytes. Together, these observations
suggest a deficiency in CAST/EiJ mice in leukocyte
adhesion and/or recruitment. The recruitment of leuko-
cytes to the site of infection is a complex process of dif-
ferent steps including leucocyte rolling, activation, arrest
and transmigration into the tissue which involves many
proteins and interactions. Three types of leukocyte adhe-
sion deficiencies (LADI-III) have been described in
humans (reviewed in [95]). Mutations in ITGB2 (integrin
beta 2), SLC35C1 (solute carrier family 35) and FERMT3
(fermitin family homolog 3) have been identified as the
genetic cause of disease in LADI, II and III, respectively
[95]. However, we did not observe differences in the ex-
pression of these LAD genes in CAST/EiJ mice (data
not shown). Thus the specific CAST/EiJ phenotype may
be a valuable model system to identify and study add-
itional genes related to human leukocyte adhesion and
recruitment deficiencies. Of course, further functional
analyses under different conditions will be necessary to
describe the leukocyte phenotype in CAST/EiJ mice in
more detail.
Conclusion
In conclusion, our studies on the CC founder strains
emphasize the importance of host genetic back-
grounds for the course and outcome of IAV infec-
tions. The CC founder strains as well as the CC
strains will thus represent an extremely valuable ex-
perimental model system to understand the biological
mechanisms as well as the genetic factors that cause
severe influenza disease in humans. In most cases,
high mortality was associated with high viral loads
and a strong immune response. However, we also
observed unexpected phenotype combinations such as
high viral load but a weak immune response. In
particular, the CAST/EiJ strain may provide a novel
model for human leukocyte adhesion and recruitment
deficiencies.
Methods
Ethics statement
All experiments in mice were approved by an external
committee according to the national guidelines of the
animal welfare law in Germany (BGBl. I S. 1206, 1313
and BGBl. I S. 1934). The protocol used in these experi-
ments has been reviewed by an ethics committee
(equivalent to US IACUC, according to the German
law) and approved by the ‘Niedersächsisches Landesamt
für Verbraucherschutz und Lebensmittelsicherheit,
Oldenburg, Germany’ (Permit Numbers: 33.9.42502-04-
051/09 and 3392 42502-04-13/1234).
Virus, mouse strains, infection
The mouse-adapted virus strain influenza A/HK/01/
68,obtained from Otto Haller, University of Freiburg [96]
was produced in the allantoic cavity of 10-day-old em-
bryonated hen eggs for 48 h at 37 °C. The CC founder
(A/J, C57BL/6J, 129S1/SvlmJ, NOD/ShiLtJ, NZO/HILtJ,
CAST/EiJ, PWK/PhJ, WSB/EiJ) were purchased from
Jackson Laboratories (Bar Harbor, ME) and bred in our
animal facility in Braunschweig for two to six genera-
tions depending on the respective strain. All mice were
maintained under specific pathogen free conditions and
according to the German animal welfare law. The entire
age range of mice was 7 to 13 weeks whereby 95.5 % of
the mice had an age range of 8–12 weeks. Female and
male mice were anesthetized by intra-peritoneal injec-
tion with a mixture of Ketamine/Xylazine (100 mg/ml
Ketamine and 20 mg/ml Xylazine) in sterile natrium
chloride solution. The doses were adjusted to the indi-
vidual body weight using 200 μl/20 g body weight. Mice
were then intra-nasally infected with 20 μl virus solution
of sterile phosphate-buffered saline using different virus
concentrations (1 × 101, 2 × 103 and 2 × 105 FFU). Body
weight was determined daily as % of initial weight at day
0. Mice that lost more than 30 % of their body weight
had to be killed for ethical reasons and were also scored
as dead. Three different experimental setups with com-
bination of different phenotyping parameters were used
(Table 2).
Relative lung weight
Mock-infected and infected female mice (n = 3-6 per
strain and time point) were anesthetized using 160 μl
Isofluoran (cp-pharma, Burgdorf, Germany). After ex-
sanguinating via puncture of the retro-bulbar vein
plexus, lungs were collected and weighted directly.
Relative lung weight was calculated as followed: (lung
weight on day of preparation/body weight on day of
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preparation) × 100 and displayed as percentage of total
body weight.
Viral load in lungs
Viral load in infected lungs was determined on MDCK II
(Madin-Darby Canine Kidney II) cells using the FFU assay
as described previously [53]. Briefly, lungs of mice were
homogenized and debris removed by centrifugation. Sam-
ples were stored in aliquots at −70 °C. Serial dilutions of
lung homogenates were prepared and viral titers deter-
mined by the FFU assay.
RNA isolation for arrays
At different time points after virus infection (day 3 and
5) and mock infection (day 3 post sterile phosphate-
buffered saline infection) lung and blood were taken for
RNA isolation. Body weight was measured until the day
of sample collection. Eye blood was collected in RNA
protect animal blood tubes (Qiagen) and immediately
stored at −20 °C. Lung RNA was isolated using Qiagen
Midi Kit as described previously (104). Blood RNA was
isolated with the RNeasy protect animal blood kit (Qia-
gen). RNA concentration was measured with the Nano-
Drop (Thermo Scientific).
Microarray experiment
For DNA microarray hybridization and analysis, the quality
and integrity of the total RNA was controlled on a 2100
Bioanalyzer (Agilent Technologies; Waldbronn, Germany).
100 ng of total RNA were applied for Cy3-labelling reaction
using the one color Quick Amp Labeling protocol (Agilent
Technologies; Waldbronn, Germany). Labeled cRNA was
hybridized to Agilent’s mouse 4 × 44 k microarrays for 16 h
at 68 °C and scanned using the Agilent DNA Microarray
Scanner. Expression values were calculated by the software
package Feature Extraction 10.5.1.1 (Agilent Technologies;
Waldbronn, Germany).
Statistics
Data were analyzed using GraphPad Prism version 5.04
for Windows (GraphPad Software, San Diego, California).
Mean and standard error of the mean (SEM) were calcu-
lated for all groups. Dunn’s post test with multiple testing
correction was used for significance testing between indi-
vidual groups (e.g. different gender, virus concentration
and time points). Non-parametric Mann Whitney U test
was used to determine p-values for the significance of dif-
ferences between two groups. Log rank test was used to
calculate significances for survival rates. Analysis of vari-
ance (ANOVA) was performed using the lm and aov func-
tions of the R software package [97]. A multi-factorial
ANOVA model (weight-loss ~ strain * sex * day) with all
interaction terms and with days (from day 1 to day 7 p.i.)
as a categorical factor was used first. In this analysis, the
three-way interaction term strain:day:sex was not signifi-
cant and was therefore removed to generate an optimized
ANOVA model (Additional file 2: Table S2). Subsequent
Tukey HSD post-hoc test was used to identify pairwise
significant differences. A one-way ANOVA was performed
using the model weight-loss ~ strain for each individual
day separately, and the broad-sense heritability was deter-
mined by calculating the interclass correlation [98]: (MSB-
MSW)/(MSB+(n-1)*MSW) with MSB =mean square
between groups, MSW=mean square within groups, n =
mean number of mice per strain. One way ANOVA (model
lg.viral.ld ~ suscept, see (Additional file 4: Table S4 and
Additional file 5: Table S5 for details) and Tukey HSD
post-hoc test was used to determine differences of viral
load between strains of different susceptibility (intermedi-
ate susceptible, highly susceptible and resistant strains).
Correlations for phenotypic traits were calculated and illus-
trated using R scripts developed by W. Venables (http://
goo.gl/nahmV), S. Turner (https://gist.github.com/stephen-
turner/3492773) and the graphics from the package Perfor-
manceAnalytics (https://cran.r-project.org/).
Gene expression analysis
Array data were analyzed using the R software package
[97]. Pre-processing steps included background correc-
tion, quantile normalization and annotation using the
MmAgilentDesign026655.db [99], limma [100], and
Agi4 × 44PreProcess [101] packages. Principal compo-
nent analysis (PCA) analysis were performed using the
affycoretools package [102]. Multi-group comparisons
and identification of differentially expressed probe sets
(DEPS) were performed with the LIMMA package [100]
using BH correction for multiple testing [103]. DEPS
were identified based on an adjusted p-value of < 0.05
and exhibiting more than a two-fold difference in ex-
pression levels (abs [log2] > 1). Inflammatory genes that
are expressed during influenza infections were selected
based on our previous influenza transcriptome studies
[35, 104]. GO, KEGG, Reactome enrichment analysis
and cluster profiling was performed with the package
clusterProfiler [105]. For the identification of genes that
exhibited no change in gene expression levels after infec-
tion in the lungs of CAST/EiJ mice compared to the
other strains, the full expression data set was filtered for
probe sets that were not regulated in CAST/EiJ (log-fold
change absolute <0.5) but up-regulated in C57BL/6J and
129S1/SvlmJ mice at days 3 and 5 after infection (log-
fold change absolute >1). In addition, the data set was
filtered for probe sets that were down-regulated in
CAST/EiJ (log-fold change < −0.5) but up-regulated in
C57BL/6 J and 129S1/SvlmJ mice at days 3 and 5 after
infection (log-fold change absolute >1). These filters
returned 8 and 2 probe sets, respectively. It should, how-
ever, be noted that gene expression differences between
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strains which are observed in Agilent arrays may not al-
ways represent true differences in expression levels be-
tween strains but may also result from sequence
polymorphisms in transcripts that result in mismatches
between probes and transcripts, since the probes on the
array are based on the C57BL/6J reference strain. There-
fore, we validated true expression changes by analyzing
the respective genes in a previously published RNAseq
data set [31]. Only genes that were also differentially
expressed in the RNAseq data set were further investi-
gated. In this way, eight genes were found to be regu-
lated in CAST/EiJ versus the other strains. The same
analysis was performed for blood transcriptomes. Four
DEPS were not regulated in CAST/EiJ (log-fold change
absolute <0.5) but up-regulated in C57BL/6J and 129S1/
SvlmJ mice at days 3 and 5 after infection (log-fold
change absolute >1). KEGG pathway analysis was per-
formed using the pathview package in R [106]. DCQ
analysis was performed according to the algorithm de-
scribed in [36]. Gene expression values were pre-
processed by subtracting the mean of the mock-infected
mice from the infected mice for each mouse strain and
by selecting the most variant probe sets for genes with
multiple probe sets based on the standard deviation
across all groups. DCQ analysis was then performed at
the public server provided by the University of Tel Aviv
(http://dcq.tau.ac.il/). The results were then visualized by
heatmaps using the R software [97].
Histology
Tissues were stored in 10 % neutral-buffered formalin
(lungs after careful inflation with formalin), embedded in
paraffin, sectioned at 4 μm, and stained with
hematoxylin and eosin (HE) for examination by light mi-
croscopy. Semi-quantitative assessment of influenza
virus-associated inflammation by histopathology in the
lung was performed as reported earlier [107] for the ex-
tent of alveolitis and alveolar damage we scored: 0, 0 %;
1, 1-25 %; 2, 25-50 %; 3, > 50 %. For the severity of alve-
olitis, bronchiolitis and bronchitis we scored: 0, no
inflammatory cells; 1, few inflammatory cells; 2, moder-
ate numbers of inflammatory cells; 3, many inflamma-
tory cells. For the presence of alveolar edema, alveolar
hemorrhage and type II pneumocyte hyperplasia we
scored: 0, no; 1, yes. Finally, for the extent of peribron-
chial, peribronchiolar and perivascular infiltrates we
scored: 0, none; 1, one to two cells thick; 2, three to ten
cells thick; 3, more than ten cells thick. Slides were ex-
amined without knowledge of the animals.
Immunohistochemistry
For detection of influenza A virus antigen, tissues were
stained with a primary antibody against the influenza A
nucleoprotein as described previously [108]. In each
staining procedure, an isotype control was included as a
negative control. Semi-quantitative assessment of influ-
enza virus antigen expression in the lungs was performed
as reported earlier [107] with minor modification: for the
alveoli, 25 arbitrarily chosen, 20× objective fields of lung
parenchyma per animal were examined by light micros-
copy for the presence of influenza virus nucleoprotein,
without the knowledge of the identity of the animals. The
score for each animal was presented as the percentage of
positive fields. For the bronchi and bronchioles, the per-
centage of positively staining epithelium was estimated on
every slide to provide the score per animal: 0, 0 %; 1, 1-
25 %; 2, 25-50 %; 3, > 50 %.
The numbers of neutrophils and intraluminal macro-
phages were counted in 20 arbitrarily chosen, 40× objective
fields per animal. Slides were examined without knowledge
of the identity of the animals. Viable neutrophils were iden-
tified by immunohistochemistry staining with primary anti-
body Ly-6G (rat-anti-mouse Ly-6G, 25–5931, eBioscience,
San Diego, USA). Binding of the primary antibody was de-
tected using a peroxidase labeled rabbit-anti-rat IgG-HRP
(p0450, DAKO, Denmark). Peroxidase activity was revealed
using 3-amino-9-ethylcafrbazole (AEC) (Sigma, St Louis,
MO, USA). Intraluminal macrophages were identified on
the basis of their morphology and location as described
previously [109].
Hematology
For monitoring hematological parameters, female mice
were anesthetized using 160 μl isoflourane at different
time points (mock day 3, day 3, 5, 8, 18 and day 30) after
infection. Time points were omitted from the analysis
when less than 60 % of the infected mice survived infec-
tion within a strain. Blood was taken by puncture of the
retrobulbar vein plexus, collected in micro tubes con-
taining EDTA (Sarstedt) and immediately measured in
the hematologic system VetScan HM5 (Abaxis). The
absolute cell numbers of lymphocytes, granulocytes and
monocytes were determined and calculated as percent-
age of white blood cells.
Flow cytometry
Immune cell populations of single animals were analyzed
in cell suspensions derived from homogenized lungs or
whole blood. Blood was collected as described for the
haematological analysis. Antibody against CD16/32 (clone
2.4G2) was added to blood minimizing unspecific binding
to Fcy receptors. Blood cells were directly stained in two
different panels with the following antibodies: αCD4-PE
(BD Bioscience, Europe), αCD8-APC, αCD11b-APC,
αCD19-FITC, αCD115-Alexa Fluor 488, αLy-6G-PE-Cy7
and αNKp46-PerCP-eFluor 710 (eBioscience). After incu-
bation at 4 °C for 30 minutes, in the dark, erythrocytes
were lysed and cells fixed in FACS Lysing Solution (BD
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Bioscience), and washed twice with PBS/2%FCS. Lungs
prepared from the same animals were passed through a
100 μm-cell strainer and a density centrifugation using
Lympholyte M (Cedarlane) was performed. After washing
the cells obtained from the interphase twice with PBS/
2%FCS, Fcy receptors were blocked with αCD16/32 and
subsequently stained with antibodies as described above.
In addition αF4/80-FITC and αCD11c-PE (eBioscience)
were used. To exclude dead cells, 1 μg propidium iodide
was added to each sample. Samples were measured using
an Accuri C6 flow cytometer (BD Bioscience). Data were
analyzed using FlowJo version 7.6.5 (Tree Star, Ashland,
Oregon). The marker expression and gating strategy of
immune cell populations was done as described [53].
Minor subpopulations like CD8 + DC were not
considered.
Deposition of data
Array data have been deposited at the gene expression
data base GEO (GSE74077), phenotype data will be de-
posited at the mouse phenome database (MPD, [110])
upon publication of the manuscript.
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